Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07224685 · ClinicalTrials.gov registry record
A Study of Mayo Clinic CV Research Heart & Voice Study
A clinical trial of Cardiovascular Diseases, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 1,000,000
- Enrollment target
- 1
- Study location
NCT07224685: Recruiting study of Cardiovascular Diseases, sponsored by Mayo Clinic.
NCT07224685 is a study of Cardiovascular Diseases that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 1,000,000 participants, above the 23,641-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (4130% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07224685, a study of Cardiovascular Diseases, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 1,000,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine whether voice recordings acquired from patient-owned Android and Apple (iOS) smartphones can be used to monitor cardiovascular health. Voice signals will be processed to determine whether we can detect presence of cardiovascular disease and wellness, or if health risks exist.
Primary Outcome
The total number of patients who recorded a voice sample will be defined as those completing a 30-second to 2-minute video, pronouncing vowel sounds or reading a short script as prompted by the Mayo Clinic App.
Conditions Studied
Interventions
- OTHER Voice Recording
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000,000 participants |
| Start Date | 2024-03-05 |
| Est. Completion | 2029-03 |
What NCT07224685 shows while recruiting
NCT07224685 is an observational study that tracks outcomes without assigning an intervention. Its 1,000,000 participants enrollment target places it among the larger protocols in the corpus, above the 23,641-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (4130% higher).
The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Voice Recording is the first listed.
NCT07224685 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07224685 about?
NCT07224685 is a clinical study titled "A Study of Mayo Clinic CV Research Heart & Voice Study". The purpose of the study is to determine whether voice recordings acquired from patient-owned Android and Apple (iOS) smartphones can be used to monitor cardiovascular health. Voice signals will be processed to determine whether we can detect presence of cardiovascular disease and wellness, or if he...
What is the current status of trial NCT07224685?
This trial is currently recruiting. The enrollment target is 1,000,000 participants. The study started on 2024-03-05. Estimated completion is 2029-03.
What conditions does trial NCT07224685 study?
This clinical trial studies the following conditions: Cardiovascular Diseases.
What interventions are being tested in trial NCT07224685?
The interventions under investigation include: Voice Recording (OTHER).
Who is sponsoring clinical trial NCT07224685?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07224685 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07224685's enrollment target sits among peer trials
1,000,000 3rd of 300 higher than 298 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05066763 · 1,000,000 participants
Parkinson's Foundation Surveys
- NCT07075341 · 1,000,000 participants
Healthy Living BEYOND Weight Study
- NCT06029933 · 960,000 participants
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
- NCT01073475 · 950,000 participants
Maternal Newborn Health Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI